Blood Cancer Journal (Feb 2024)
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity
- Ioannis V. Kostopoulos,
- Despina Fotiou,
- Maria Gavriatopoulou,
- Pantelis Rousakis,
- Ioannis Ntanasis-Stathopoulos,
- Chrysanthi Panteli,
- Panagiotis Malandrakis,
- Magdalini Migkou,
- Nikolaos Angelis,
- Nikolaos Kanellias,
- Evangelos Eleutherakis-Papaiakovou,
- Foteini Theodorakakou,
- Maria Krevvata,
- Evangelos Terpos,
- Meletios-Athanasios Dimopoulos,
- Ourania Tsitsilonis,
- Efstathios Kastritis
Affiliations
- Ioannis V. Kostopoulos
- Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens
- Despina Fotiou
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Maria Gavriatopoulou
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Pantelis Rousakis
- Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens
- Ioannis Ntanasis-Stathopoulos
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Chrysanthi Panteli
- Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens
- Panagiotis Malandrakis
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Magdalini Migkou
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Nikolaos Angelis
- Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens
- Nikolaos Kanellias
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Evangelos Eleutherakis-Papaiakovou
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Foteini Theodorakakou
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Maria Krevvata
- Janssen Research & Development
- Evangelos Terpos
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Meletios-Athanasios Dimopoulos
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- Ourania Tsitsilonis
- Flow Cytometry Unit, Department of Biology, School of Science, National and Kapodistrian University of Athens
- Efstathios Kastritis
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens
- DOI
- https://doi.org/10.1038/s41408-024-00988-x
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 4
Abstract
No abstracts available.